用于重塑残留大动脉剖析的分期重新干预:单中心回顾性研究
Bailang Chen1, Kunpeng Huang2, Xianmian Zhuang1
1Department of Cardiovascular Surgery, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China.
Frontiers in cardiovascular medicine
|May 27, 2024
概括
对于残留大动脉解剖 (RAD) 的分阶段再干预是安全有效的,没有增加死亡率. 这种方法改善了大动脉重塑,为患者提供了有前途的结果,大动脉解剖后修复.
科学领域:
- 心血管外科心血管外科
- 血管外科 血管外科
- 干预心脏病学 干预心脏病学
背景情况:
- 斯坦福A或B修复后的剩余大动脉剖析 (RAD) 是死亡率的关键预测因素.
- 不充分的大动脉重塑对患者构成重大风险.
研究的目的:
- 评估RAD阶段性重新干预的短期到中期结果.
- 评估使用分阶段支架干预措施治疗RAD的安全性和有效性.
主要方法:
- 从2019年7月到2021年12月的回顾性数据收集.
- 54名RAD患者的比较:分阶段重新干预 (SR) 组中的33名和非手术组中的21名.
- 分析死亡率,内脏分支封闭,需要进一步干预,不良事件和形态变化.
主要成果:
- 在SR和非手术组之间,所有原因或主动脉相关死亡率没有统计学上显著的差异 (0%主动脉死亡率).
- 在SR组中有一种并发症 (动脉血栓症).
- 在SR组中改善了大动脉重塑,增加了真光和减少了假光面积.
结论:
- 对RAD进行分阶段的重新干预是一种安全的策略.
- 这种方法证明了有希望的早期结果,改善了大动脉重塑和患者的治疗结果.
相关概念视频
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...


